HER 2(+) new therapeutic alternatives in HER 2(+) breast cancer, Pregnancy in breast cancer, and Are we ready to individualize chemotherapy by breast cancer subtype? 

 -  2015 
<br/><br/><label>Subjects--Geographic Terms: </label><br/>Washington Cancer Institute